Stay updated on Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page.

Latest updates to the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page
- Check6 days agoChange DetectedA new revision v3.5.2 was added. The previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedRevision history now includes v3.5.0 and removes v3.4.3 from the list.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision history shows the latest revision is v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check71 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and older notices such as the funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.9%

- Check78 days agoChange DetectedThe page adds a government funding lapse notice and the record history shows a new version (v3.4.1) replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check85 days agoChange DetectedA Record History view with versioned changes is added, showing submitted dates, changes, and color-coded additions/deletions. New UI elements such as Show glossary, Researcher View, Study Details, Save, and Download are introduced.SummaryDifference8%

Stay in the know with updates to Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page.